CDKN2A and astrocytoma (excluding glioblastoma): IDH-mutant astrocytomas are considered a distinct entity and categorized as Grade 2, 3, or 4, while CDKN2A/B deletions provide further subclassification to IDH-mutant astrocytomas (7).